Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
12.62
-0.29 (-2.25%)
At close: Jan 31, 2025, 4:00 PM
13.25
+0.63 (4.99%)
After-hours: Jan 31, 2025, 5:46 PM EST
Bicara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -59.48 | -51.99 | -37.85 |
| Depreciation & Amortization | 0.06 | 0.02 | 0.01 |
| Asset Writedown & Restructuring Costs | 0.57 | 0.57 | - |
| Stock-Based Compensation | 4.98 | 1.9 | 0.81 |
| Other Operating Activities | 0.31 | 13.5 | - |
| Change in Accounts Payable | 1.4 | -8.66 | 5.87 |
| Change in Other Net Operating Assets | -0.59 | -0.96 | -0.92 |
| Operating Cash Flow | -52.76 | -45.63 | -32.08 |
| Capital Expenditures | -0.47 | -0.59 | -0.19 |
| Investing Cash Flow | -0.41 | -0.59 | -0.19 |
| Issuance of Common Stock | 335.01 | 0.15 | 0.16 |
| Financing Cash Flow | 529.71 | 272.5 | 31.7 |
| Net Cash Flow | 476.55 | 226.28 | -0.57 |
| Free Cash Flow | -53.22 | -46.21 | -32.27 |
| Free Cash Flow Per Share | -16.19 | -79.66 | -75.20 |
| Cash Income Tax Paid | - | - | 0 |
| Levered Free Cash Flow | - | -32.5 | - |
| Unlevered Free Cash Flow | - | -32.5 | - |
| Change in Net Working Capital | - | 8.9 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.